Published in J Eur Acad Dermatol Venereol on April 01, 2010
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol (2010) 2.37
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc (2013) 1.25
Targeting of interleukin-17 in the treatment of psoriasis. Clin Cosmet Investig Dermatol (2014) 0.93
Management of moderate to severe psoriasis in patients with metabolic comorbidities. Front Med (Lausanne) (2015) 0.87
Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol (2014) 0.85
Cardiovascular comorbiditiy in psoriasis. Indian J Dermatol (2011) 0.83
Psoriatic disease and tuberculosis nowadays. Clin Dev Immunol (2012) 0.81
Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis. Clin Cosmet Investig Dermatol (2011) 0.81
Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression. J Diabetes Res (2015) 0.80
Metabolic syndrome and its components in patients with psoriasis. Springerplus (2014) 0.79
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting. J Clin Aesthet Dermatol (2013) 0.79
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol (2017) 0.75
Primary care-based screening for cardiovascular risk factors in patients with psoriasis. Br J Dermatol (2016) 0.75
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol (2013) 0.75
Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J (2016) 0.75
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis. Clin Drug Investig (2017) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg (1996) 5.05
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
First sexual intercourse: age, coercion, and later regrets reported by a birth cohort. BMJ (1998) 3.14
Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun (1995) 3.08
Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03
Complete amino acid sequence of the Mu heavy chain of a human IgM immunoglobulin. Science (1973) 2.97
Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ (2000) 2.87
Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem (1999) 2.85
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85
Oral contraceptives and fatal pulmonary embolism. Lancet (2000) 2.57
Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med (1992) 2.54
Folding patterns of porin and bacteriorhodopsin. EMBO J (1985) 2.34
Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34
[Survival after cutaneous metastasis: a study of 200 cases]. Ann Dermatol Venereol (2001) 2.26
Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol (1995) 2.25
Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis (1988) 2.19
Sequence relationships of three human satellite DNAs. J Mol Biol (1986) 1.93
Waiting for elective surgery: effects on health-related quality of life. Int J Qual Health Care (1999) 1.90
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol (2002) 1.81
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol (1997) 1.73
Hepatitis C virus in dermatology. A review. Arch Dermatol (1995) 1.71
Mammographic screening: results from the 1996 National Breast Health Survey. Med J Aust (1997) 1.71
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med (1994) 1.69
In vitro and in vivo anti-melanoma effects of ciglitazone. J Invest Dermatol (2009) 1.67
Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. Arch Dermatol (1995) 1.64
Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest (1993) 1.62
The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) (2001) 1.62
Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians. J Eur Acad Dermatol Venereol (2014) 1.60
Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn (1995) 1.59
Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood (2000) 1.59
Importance of the male factor in cancer of the cervix. Lancet (1982) 1.58
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
Epidemiology of pelvic ring injuries. Injury (1996) 1.58
Sample-specific ratio effects in matching to sample. J Exp Anal Behav (1983) 1.58
Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy (2006) 1.57
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
CD4+ lymphocytopenia without HIV in patient with cryptococcal disease. Lancet (1991) 1.52
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol (2013) 1.50
Occurrence of AIDS in New Zealand: the first seven years. MRC AIDS Epidemiology Group. N Z Med J (1991) 1.48
Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones (2001) 1.47
Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol (2011) 1.47
Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res (1999) 1.47
Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies. J Eur Acad Dermatol Venereol (2014) 1.47
Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS (2001) 1.46
Pregnancies among New Zealand teenagers: trends, current status and international comparisons. N Z Med J (2000) 1.44
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol (1991) 1.44
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol (2007) 1.44
[Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma]. Ann Dermatol Venereol (2013) 1.44
Revisiting the enzymes stored in the laticifers of Carica papaya in the context of their possible participation in the plant defence mechanism. Cell Mol Life Sci (2001) 1.43
Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol (2001) 1.43
Patterns of disease and HIV testing at sexually transmitted disease clinics. N Z Med J (1997) 1.43
A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol (2002) 1.42
High-frequency ultrasonography but not 930-nm optical coherence tomography reliably evaluates melanoma thickness in vivo: a prospective validation study. Br J Dermatol (2014) 1.42
Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia. Br J Dermatol (2011) 1.42
Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol (2001) 1.42
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia (2010) 1.41
Epithelial sheath neuroma: a new entity. Am J Surg Pathol (2000) 1.40
Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm Venereol (1996) 1.40
[Vulvar vestibulitis syndrome: a clinicopathological study of 14 cases]. Ann Dermatol Venereol (2008) 1.40
Increased prevalence of psoriasis in patients with coronary artery disease: results from a case-control study. Br J Dermatol (2014) 1.39
Oral contraceptives and venous thromboembolism continued. N Z Med J (2000) 1.39
[Benign desmoplastic fibroblastoma of the lower leg. A rare case]. Unfallchirurg (2004) 1.39
The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol (2012) 1.39
Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 patients from a dermatological consultation. Br J Dermatol (2014) 1.38
[Medical activity in a emergency outpatient department dermatology]. Ann Dermatol Venereol (2003) 1.38
[Melanoma in the Strasbourg University Hospital. A 30-year study]. Ann Dermatol Venereol (1998) 1.38
[Contact vasculitis caused by topical agents with non-steroidal anti-inflammatory agents or analgesics]. Ann Dermatol Venereol (1997) 1.38
Incidence of cancer among Pacific Island people in New Zealand. N Z Med J (1993) 1.38
The extent of cervical screening in New Zealand women. N Z Med J (1991) 1.38
Acral persistent papular mucinosis and IgA monoclonal gammopathy: report of a case. Dermatology (1992) 1.38
[Did you say lentigo?]. Ann Dermatol Venereol (2003) 1.38
[Neutrophilic eccrine hidradenitis in a healthy patient]. Ann Dermatol Venereol (2005) 1.37
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37
A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene (2009) 1.33
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol (1999) 1.32
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol (2009) 1.32
A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens (2011) 1.31
The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways. Oncogene (2009) 1.30
Effects of maternal nutrition on the human fetus. Pediatrics (1973) 1.30
Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ (1990) 1.30
Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol (2001) 1.28
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol (2013) 1.27